CTOs on the Move

Visby Medical

www.visbymedical.com

 
Driven by a belief that results should be quick, accurate, and accessible to all, our device platform aims to redefine the way we test and treat illness.
  • Number of Employees: 250-1000
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Visby Medical raised $12.3M on 02/02/2021
Visby Medical raised $100M on 03/01/2022

Similar Companies

Dionex Corporation

Dionex Corporation (Dionex) designs, manufactures, markets, and services analytical instrumentation, related accessories, and chemicals. Its products are used to analyze chemical substances in the environment and in a range of industrial and scientific

Deymed Diagnostic

Deymed Diagnostic is a Payette, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

brookdale medical

brookdale medical is a Woodbridge, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pgc Scientifics Corporation

Pgc Scientifics Corporation is a Frederick, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GenMark Diagnostics

In 1993, a novel technology was invented by a team that included Jon Faiz Kayyem, PhD at The California Institute of Technology (CalTech). This invention combined nucleic acids and microelectronics to produce an electronic sensor for DNA detection. His invention was based on electrical detection of nucleic acids on a cassette based detection platform. Dr. Kayyem went on to found Clinical Micro Sensors, with the goal of translating this “eSensor” technology to disposable chips. Following several acquisitions of the technology, Dr. Kayyem became actively involved again in 2009, returning as an investor and then as CEO and Chairman of the Board. In 2009, a collaboration between Dr. Kayyem and Christopher Gleeson began. The two redefined the company strategy, and brought in a new board of directors, executive leadership team, and commercial management. In 2010, the company known at that time as Osmetech, was named GenMark Diagnostics and listed on NASDAQ. Mr. Gleeson remained an integral part of GenMark`s growth in the years that followed, serving as Chairman of the Board until his retirement in 2014. Dr. Kayyem currently serves as SVP, Research and Development.